Dechra Pharmaceuticals (DPH)


DPH Share PerformanceMore

52 week high2,272.0 28/11/17
52 week low1,396.0 24/01/17
52 week change 627.0 (43.57%)
4 week volume2,842,467 27/12/17

Latest NewsMore

Broker Forecast - Jefferies International issues a broker note on Dechra Pharmaceuticals PLC

Jefferies International today reaffirms its hold investment rating on Dechra Pharmaceuticals PLC (LON:DPH) and set its ...

Festive cheer for Morrisons supports firm FTSE

A rally in UK grocers kept the FTSE travelling higher thanks to encouraging Christmas trading from Morrisons (MRW). ...

Upbeat trading at Morrison's lifts grocery stocks

Supermarkets rallied on the back of Morrison's strong Christmas trading, helping to push the FTSE 100 0.3% higher to 7,724...

Dechra sees double-digit revenue growth

Dechra Pharmaceuticals said trading in the period from the start of July to the end of December was strong and in line w...

Trading Update & Notice of Half-Year Results

RNS Number: 2872B Dechra Pharmaceuticals PLC 09 January 2018 Tuesday, 9 January 2018 Dechra Pharmaceuticals PLC (Dechra, Group, Company) Trading Update The Board of Dechra issues the following unaudited Trading Update covering the half year reporting period from 1 July to 31 December 2017 (the Period). Highlights Trading in the Period was strong a...

Total Voting Rights

Notification of a change in the total number of voting rights

Holding(s) in Company

Notification of major interests in shares

Total Voting Rights

Notification of a change in the total number of voting rights

Fundamental DataMore

P/E ratio73.549
Dividend yield1.038 %

Latest discussion posts More

  • H1 Results 'in line'

    Brief update today with full Interims on 26th Feb. USA revenues are up more than those for Europe. They have bought their New Zealand distributor. A lot of companies with ...
  • now cantor fitzgerald....

    .....telling clients to buy #22 .new suit for xmas if they hit this target !!
  • Re: numis says add

    That sounds positive Valeite. I think that this one may be a bit volatile as the valuation is so high that any bit of negative news could cause an exaggerated fall. From ...
    frog in a tree

Users' HoldingsMore

Users who hold Dechra Pharmaceuticals also hold..

Codes & Symbols


Join interactive investor

  • £22.50 fixed quarterly charge includes £22.50 in trading credits
  • £10 per trade or £6 for frequent traders
  • No % platform fees
  • £1 per trade for regular investment or dividend reinvestment

Open an account